Munich - Delayed Quote EUR

Sotera Health Company (SH5.MU)

10.60
-0.20
(-1.85%)
As of 8:00:09 AM GMT+2. Market Open.
Loading Chart for SH5.MU
  • Previous Close 10.80
  • Open 10.60
  • Bid 10.70 x --
  • Ask 10.90 x --
  • Day's Range 10.60 - 10.60
  • 52 Week Range 8.60 - 15.20
  • Volume 0
  • Avg. Volume 0
  • Market Cap (intraday) 3.009B
  • Beta (5Y Monthly) 1.87
  • PE Ratio (TTM) 132.50
  • EPS (TTM) 0.08
  • Earnings Date Aug 4, 2025 - Aug 8, 2025
  • Forward Dividend & Yield --
  • Ex-Dividend Date --
  • 1y Target Est --

Sotera Health Company provides sterilization, lab testing, and advisory services for the healthcare industry in the United States, Canada, Europe, and internationally. The company operates through three segments: Sterigenics, Nordion, and Nelson Labs. The Sterigenics segment offers outsourced terminal sterilization and irradiation services using gamma irradiation, ethylene oxide processing, and electron beam irradiation technologies for the medical device, pharmaceutical, and food safety and advanced applications markets. The Nordion segment provides Cobalt-60 used in the sterilization and irradiation processes for the medical device, pharmaceutical, food safety, and high-performance materials industries, as well as in the treatment of cancer. It also offers gamma irradiation systems. The Nelson Labs segment provides outsourced microbiological and analytical chemistry testing and advisory services for the medical device and pharmaceutical industries. The company was formerly known as Sotera Health Topco, Inc. and changed its name to Sotera Health Company in October 2020. Sotera Health Company was incorporated in 2015 and is headquartered in Broadview Heights, Ohio.

soterahealth.com

3,000

Full Time Employees

December 31

Fiscal Year Ends

Recent News: SH5.MU

View More

Performance Overview: SH5.MU

Trailing total returns as of 6/9/2025, which may include dividends or other distributions. Benchmark is S&P 500 (^GSPC) .

YTD Return

SH5.MU
15.87%
S&P 500 (^GSPC)
2.02%

1-Year Return

SH5.MU
7.02%
S&P 500 (^GSPC)
12.22%

3-Year Return

SH5.MU
52.68%
S&P 500 (^GSPC)
49.34%

5-Year Return

SH5.MU
50.23%
S&P 500 (^GSPC)
87.09%

Compare To: SH5.MU

Select to analyze similar companies using key performance metrics; select up to 4 stocks.

Statistics: SH5.MU

View More

Valuation Measures

Annual
As of 6/6/2025
  • Market Cap

    3.05B

  • Enterprise Value

    4.83B

  • Trailing P/E

    137.43

  • Forward P/E

    --

  • PEG Ratio (5yr expected)

    --

  • Price/Sales (ttm)

    3.18

  • Price/Book (mrq)

    8.48

  • Enterprise Value/Revenue

    5.00

  • Enterprise Value/EBITDA

    13.31

Financial Highlights

Profitability and Income Statement

  • Profit Margin

    2.24%

  • Return on Assets (ttm)

    7.01%

  • Return on Equity (ttm)

    5.88%

  • Revenue (ttm)

    1.11B

  • Net Income Avi to Common (ttm)

    24.78M

  • Diluted EPS (ttm)

    0.08

Balance Sheet and Cash Flow

  • Total Cash (mrq)

    304.61M

  • Total Debt/Equity (mrq)

    566.88%

  • Levered Free Cash Flow (ttm)

    194.97M

Research Analysis: SH5.MU

View More

Company Insights: SH5.MU

Research Reports: SH5.MU

View More

People Also Watch